Topics
- COVID-19 (101)
- Advertising (74)
- COVID-19 vaccines (62)
- Prescription medicines (29)
- Medical devices (20)
- Regulatory compliance (18)
- Alert/Advisory (14)
- Medicines safety (9)
- In Vitro Diagnostic medical devices (IVDs) (6)
- Manufacturing (6)
- Disinfectants/Sterilants (5)
- Medicines (5)
- OTC medicines (3)
- Labelling and packaging (2)
- Shortages (2)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biologicals (1)
- Medicinal cannabis hub (1)
- Safety (1)
- Scheduling (1)
- Unapproved therapeutic goods (1)
Collection content
293 result(s) found, displaying 11 to 20
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 22-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 15-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 01-12-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 17-11-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA grants provisional determination to Pfizer’s COVID-19 bivalent (COMIRNATY BIVALENT OMICRON BA.4/BA.5) booster dose vaccineThe TGA has granted a provisional determination to Pfizer's bivalent COVID-19 vaccine candidate: tozinameran & famtozinameran (COMIRNATY BIVALENT OMICRON BA.4/BA.5 COVID-19 VACCINE).
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 03-11-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- Media releasesTGA provisionally approves Pfizer bivalent COVID-19 vaccine for use as a booster dose in adultsThe TGA has provisionally approved Pfizer’s bivalent COVID-19 vaccine, tozinameran and riltozinameran (COMIRNATY Original/Omicron BA.1) for use as a booster dose in adults 18 years and over.
- Media releasesTGA provisionally approves Moderna’s COVID-19 vaccine for use as a booster dose in individuals 12 years and olderOn 19 October 2022, the TGA provisionally approved Moderna's COVID-19 vaccine, SPIKEVAX (elasomeran), for use as a booster dose in individuals aged 12 years and older.
- COVID-19 vaccine safety reportsCOVID-19 vaccine safety report - 20-10-2022Information about the TGA's safety monitoring of COVID-19 vaccines.
- NoticesGMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemicUpdate to GMP approach to overseas manufacturers of medicines and biologicals during the COVID-19 pandemic.